Armata Pharmaceuticals Appoints David House As SVP Of Finance And Principal Financial Officer
Author: Benzinga Newsdesk | August 15, 2024 04:46pm
Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced the appointment of life sciences accounting and finance veteran David House as Senior Vice President, Finance, effective August 16th. Armata's Corporate Controller, Richard Rychlik, will retain the position of Controller.
Posted In: ARMP